Older concepts of patient empowerment are being overtaken by a potent new idea: that patients – in fact, all citizens interested in contributing to the improvement of health outcomes through innovative therapies – can have a significant voice in the funding and development of medicines.
Companies are sprouting across the pharma value chain that harness various forms of patient input into the research, development, and...